China’s National Medical Products Administration or NMPA China, renamed in 2018 from State Food and Drug Administration (CFDA China, 国家药品监督管理局) is Chinese government’s administrative body responsible for regulating pharmaceuticals, medical devices, and cosmetics in China.
NMPA China is a vice-ministerial-level administrative agency under the State Administration for Market Regulation (SAMR). It is responsible for creating and supervising the implementation of policies, plans and standards governing the quality and safety of drugs, cosmetics, and medical devices. NMPA also oversees standards-setting, registration, and quality management of drugs, cosmetics, and medical devices, as well as post-market inspection and risk management and registration of licensed pharmacists.
This is a meeting for Healthcare members, of which the aim is to share knowledge and business activities from different companies in the area of healthcare, relevant regulations applied to them from China NMPA, issues they are facing, and to inspire fruitful discussion on it.
Agenda:
9:30 - 10:00: Arrival and networking
10:00 - 10:30: Members' Presentations
10:30 - 11:30: Discussion
This is a Member-only event. To register, please click the “Register Now” button above or email Miss Yihan Zhao at yhzhao@europeanchamber.com.cn.
We look forward to seeing you there.